The Street finally gave up on the company last year - particularly since its main competitor, Illumina (ILMN), consistently beat expectations. Until a few days ago, the stock was trading far below its net cash per share. In the past week, …
Illumina (NASDAQ: ILMN) has been -- and still is -- a leader in one of the ... As a result, Illumina has been a fantastic growth stock, with its share price soaring nearly 900% since the company's IPO in 2000. But another company has …
Illumina Inc.(NASDAQ: ILMN) reported adjusted earnings of 57 cents per share ... Illumina's adjusted gross margin (considering stock-based compensation as regular expense) came in at 70.4%, up 130 basis points (bps) year over …
On Oct 9, we issued an updated research report on Illumina, Inc. ILMN. The stock currently carries a Zacks Rank #3 (Hold). Over the last three months, this San Diego, CA-based company providing tools and integrated systems for the …
Japan's Nikkei stock index plunged to a 1-1/2 month low as it followed ... Lowe's (LOW-2.27%) was upgraded to 'Buy' from 'Hold' at Jeffries. Illumina (ILMN-4.39%) was upgraded to 'Buy' from 'Neutral' at Citigroup with a price target of $275.
For example, biotech. Illumina (ILMN), which develops and manufactures equipment for genetic research, lost one-third of its market capitalization Friday after failing to meet Wall Street's revenue expectations for the third quarter. And that …
Currently, the Vetr crowd's average target price for the stock is up at $175.77, which is well above the average analyst target price of the $149.89. Less than 2 percent of Vetr users are holding ILMN in their watch lists. Latest Ratings for …
SAN DIEGO, July 1, 2015 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP is investigating whether …